157 related articles for article (PubMed ID: 16205246)
1. Documenting an adverse drug reaction.
Smith LS
Nursing; 2005 Oct; 35(10):22. PubMed ID: 16205246
[No Abstract] [Full Text] [Related]
2. FDA's sentinel network: a monumental task.
Young D
Am J Health Syst Pharm; 2007 Apr; 64(8):800-1. PubMed ID: 17420189
[No Abstract] [Full Text] [Related]
3. Human factors and medical IT systems: complex incident reporting systems and multiple IV infusions.
Colvin C; Baird P; Easty T; Trbovich P
Biomed Instrum Technol; 2013; Suppl():59-63. PubMed ID: 24111773
[No Abstract] [Full Text] [Related]
4. Incident reports are a must.
Sullivan GH
RN; 2003 Nov; 66(11):71-4. PubMed ID: 14685999
[No Abstract] [Full Text] [Related]
5. Documenting known or suspected medical device failure.
Smith LS
Nursing; 2004 Jul; 34(7):28. PubMed ID: 15241274
[No Abstract] [Full Text] [Related]
6. With REMS, what goes up can come down.
Thompson CA
Am J Health Syst Pharm; 2011 May; 68(9):783-4. PubMed ID: 21515857
[No Abstract] [Full Text] [Related]
7. Shared REMS programs expanded in 2012.
Traynor K
Am J Health Syst Pharm; 2013 Feb; 70(4):298, 303. PubMed ID: 23370134
[No Abstract] [Full Text] [Related]
8. Enhancing the reporting of "near miss" events in a children's emergency department.
Aston E; Young T
J Emerg Nurs; 2009 Sep; 35(5):451-2. PubMed ID: 19748029
[No Abstract] [Full Text] [Related]
9. Keeping it straight: the importance of keeping records.
Qld Nurse; 2005; 24(5):18. PubMed ID: 16255412
[No Abstract] [Full Text] [Related]
10. IOM panel mulls over adverse-event reporting.
Young D
Am J Health Syst Pharm; 2005 Dec; 62(24):2590-1. PubMed ID: 16333055
[No Abstract] [Full Text] [Related]
11. Where are risk evaluation and mitigation strategies headed?
Johnson PE
Am J Health Syst Pharm; 2010 Sep; 67(18):1511. PubMed ID: 20811027
[No Abstract] [Full Text] [Related]
12. Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems.
Kessler DA
Gen Hosp Psychiatry; 1994 Mar; 16(2):96-101; discussion 102. PubMed ID: 8039699
[No Abstract] [Full Text] [Related]
13. Adverse drug reactions.
Roswell R; Van Diepen LR; Jones JK; Hicks WE
Lancet; 2001 Feb; 357(9255):561-2. PubMed ID: 11229704
[No Abstract] [Full Text] [Related]
14. Data incompatibility of adverse event reports electronically submitted to the AERS database.
Glass LM
Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):212-3. PubMed ID: 18236510
[No Abstract] [Full Text] [Related]
15. Documenting adverse incidents.
Stewart KB
Nursing; 2001 Mar; 31(3):84. PubMed ID: 11288565
[No Abstract] [Full Text] [Related]
16. Reporting Adverse Drug Events.
Feagins LA; Abdelsayed GG; Schairer J;
Am J Gastroenterol; 2019 Sep; 114(9):1411-1413. PubMed ID: 31464745
[No Abstract] [Full Text] [Related]
17. FDA Encourages Reporting of Tobacco Product Adverse Experiences.
Retzky SS
Chest; 2016 Dec; 150(6):1169-1170. PubMed ID: 27938736
[No Abstract] [Full Text] [Related]
18. Issues related to risk evaluation and mitigation strategies in health-system pharmacy.
Coffey J
Am J Health Syst Pharm; 2010 Sep; 67(18):1512. PubMed ID: 20811028
[No Abstract] [Full Text] [Related]
19. Risk evaluation and mitigation strategies: challenges and opportunities for health-system pharmacists.
Stubbings J; Joshi RA; Hoffman JM
Am J Health Syst Pharm; 2010 Sep; 67(18):1547-54. PubMed ID: 20811034
[No Abstract] [Full Text] [Related]
20. Monitoring and managing adverse drug reactions.
Fincham JE
Am Pharm; 1992 Feb; NS32(2):74-81. PubMed ID: 1546634
[No Abstract] [Full Text] [Related]
[Next] [New Search]